Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators
Andrew C. Kruegel, Madalee M. Gassaway, Abhijeet Kapoor, et al.
Journal of the American Chemical Society (2016) Vol. 138, Iss. 21, pp. 6754-6764
Open Access | Times Cited: 265

Showing 1-25 of 265 citing articles:

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid, Nicole Kennedy, Nicolette C. Ross, et al.
Cell (2017) Vol. 171, Iss. 5, pp. 1165-1175.e13
Open Access | Times Cited: 471
Patterns of Kratom use and health impact in the US—Results from an online survey
Oliver Grundmann
Drug and Alcohol Dependence (2017) Vol. 176, pp. 63-70
Closed Access | Times Cited: 257
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187
7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
Andrew C. Kruegel, Rajendra Uprety, Steven G. Grinnell, et al.
ACS Central Science (2019) Vol. 5, Iss. 6, pp. 992-1001
Open Access | Times Cited: 159
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Albert Garcia‐Romeu, David J. Cox, Kirsten E. Smith, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107849-107849
Open Access | Times Cited: 144
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
New concepts in opioid analgesia
Christoph Stein
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 10, pp. 765-775
Closed Access | Times Cited: 143
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 136
Kratom use and mental health: A systematic review
Marc T. Swogger, Zach Walsh
Drug and Alcohol Dependence (2017) Vol. 183, pp. 134-140
Closed Access | Times Cited: 133
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7‐hydroxymitragynine
Scott E. Hemby, Scot McIntosh, Francisco León, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 874-885
Closed Access | Times Cited: 128
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2019) Vol. Volume 10, pp. 23-31
Open Access | Times Cited: 127
Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression
Mohammad Zafar Imam, Andy Kuo, Sussan Ghassabian, et al.
Neuropharmacology (2017) Vol. 131, pp. 238-255
Closed Access | Times Cited: 123
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research
Jack E. Henningfield, Reginald V. Fant, Daniel W. Wang
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 573-589
Open Access | Times Cited: 123
Kratom as a substitute for opioids: Results from an online survey
Marion A. Coe, Janine L. Pillitteri, Mark A. Sembower, et al.
Drug and Alcohol Dependence (2019) Vol. 202, pp. 24-32
Closed Access | Times Cited: 123
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids
Samuel Obeng, Shyam H. Kamble, Morgan E. Reeves, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 1, pp. 433-439
Open Access | Times Cited: 117
Biased Opioid Ligands
Abdelfattah Faouzi, Balázs R. Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105
Biased signaling by endogenous opioid peptides
Ivone Gomes, Salvador Sierra, Lindsay M. Lueptow, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 21, pp. 11820-11828
Open Access | Times Cited: 103
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross‐sectional study
Jonathan Schimmel, Elise Amioka, Karilynn Rockhill, et al.
Addiction (2020) Vol. 116, Iss. 1, pp. 176-181
Closed Access | Times Cited: 99
Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
Abraham Madariaga‐Mazón, Andrés F. Marmolejo-Valencia, Yangmei Li, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1719-1729
Open Access | Times Cited: 98
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
Daniel A. Todd, Joshua J. Kellogg, E. Diane Wallace, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 97
A Biased View of μ-Opioid Receptors?
Alexandra E. Conibear, Eamonn Kelly
Molecular Pharmacology (2019) Vol. 96, Iss. 5, pp. 542-549
Open Access | Times Cited: 94
Kratom policy: The challenge of balancing therapeutic potential with public safety
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, et al.
International Journal of Drug Policy (2019) Vol. 70, pp. 70-77
Open Access | Times Cited: 91
Abuse liability of mitragynine assessed with a self-administration procedure in rats
Kai Yue, Theresa Kopajtic, Jonathan L. Katz
Psychopharmacology (2018) Vol. 235, Iss. 10, pp. 2823-2829
Closed Access | Times Cited: 90
Harnessing the Chemistry of the Indole Heterocycle to Drive Discoveries in Biology and Medicine
Verrill M. Norwood, Robert W. Huigens
ChemBioChem (2019) Vol. 20, Iss. 18, pp. 2273-2297
Closed Access | Times Cited: 87
Characteristics of deaths associated with kratom use
John Corkery, Peter Streete, Hugh Claridge, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1102-1123
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top